inositol has been researched along with Ovarian Hyperstimulation Syndrome in 4 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Ovarian Hyperstimulation Syndrome: A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is insufficient evidence for an effect of inositols on ovarian reserve markers and to support their use as pretreatment before IVF/ICSI in women with polycystic ovary syndrome." | 5.01 | The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis. ( Acharya, G; Bhide, P; Gudi, A; Homburg, R; Pundir, J; Shah, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajasekaran, K | 1 |
| Malhotra, N | 1 |
| Mahey, R | 1 |
| Khadgawat, R | 1 |
| Kalaivani, M | 1 |
| Mendoza, N | 1 |
| Diaz-Ropero, MP | 1 |
| Aragon, M | 1 |
| Maldonado, V | 1 |
| Llaneza, P | 1 |
| Lorente, J | 1 |
| Mendoza-Tesarik, R | 1 |
| Maldonado-Lobon, J | 1 |
| Olivares, M | 1 |
| Fonolla, J | 1 |
| Bhide, P | 1 |
| Pundir, J | 1 |
| Gudi, A | 1 |
| Shah, A | 1 |
| Homburg, R | 1 |
| Acharya, G | 1 |
| Turan, GA | 1 |
| Eskicioglu, F | 1 |
| Sivrikoz, ON | 1 |
| Cengiz, H | 1 |
| Adakan, S | 1 |
| Gur, EB | 1 |
| Tatar, S | 1 |
| Sahin, N | 1 |
| Yilmaz, O | 1 |
1 review available for inositol and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
Topics: Anti-Mullerian Hormone; Female; Fertilization in Vitro; Humans; Inositol; Ovarian Follicle; Ovarian | 2019 |
2 trials available for inositol and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Myoinositol
Topics: Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Inositol; Metformin; Ovarian | 2022 |
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
Topics: Adolescent; Adult; Birth Rate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Compoundi | 2019 |
1 other study available for inositol and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study.
Topics: Animals; Cyclooxygenase 1; Disease Models, Animal; Estradiol; Female; Inositol; Membrane Proteins; O | 2015 |